MBP metabolic pharmaceuticals limited

trading halt, page-27

  1. 5,318 Posts.
    lightbulb Created with Sketch. 253
    Early or not, get ready: "the Company expects to make an announcement in relation to the results of its Phase 2B OPTIONS Study on obesity Drug AOD9604."

    The fact that the results are to be released this early means to me that the results are likely to be clear, unambiguous, and positive. Otherwise there would neither be the opprotunity nor the motivation for such an early release of results.

    I'm not booking any cruises just yet, but I continue to expect great things.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.